Tokyo Tape
Sign in
← Otsuka Holdings

Quarterly report · Q3

4578.TEDINET S100S3PH
Period2023-01-01 → 2023-09-30
Filed2023-10-31
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥1.48T2023-01-01 → 2023-09-30Cons.Revenue IFRS
Revenue¥531.5bn2023-07-01 → 2023-09-30dCons.Revenue IFRS
Revenue¥1.74T2022-01-01 → 2022-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.27T2022-01-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥451.8bn2022-07-01 → 2022-09-30dCons.Revenue IFRS
Operating income¥202.7bn2023-01-01 → 2023-09-30Cons.Operating profit loss IFRS
Operating income¥72.0bn2023-07-01 → 2023-09-30dCons.Operating profit loss IFRS
Operating income¥114.8bn2022-01-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥47.7bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Profit before tax¥213.2bn2023-01-01 → 2023-09-30Cons.Profit loss before tax IFRS
Profit before tax¥74.4bn2023-07-01 → 2023-09-30dCons.Profit loss before tax IFRS
Profit before tax¥173.0bn2022-01-01 → 2022-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥146.0bn2022-01-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥53.2bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥161.7bn2023-01-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥59.1bn2023-07-01 → 2023-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥133.9bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥111.0bn2022-01-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥41.3bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥165.3bn2023-01-01 → 2023-09-30Cons.Profit loss IFRS
Net income¥60.3bn2023-07-01 → 2023-09-30dCons.Profit loss IFRS
Net income¥114.0bn2022-01-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥42.4bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Total assets¥3.42Tat 2023-09-30Cons.Assets IFRS
Total assets¥3.10Tat 2022-12-31Cons.Assets IFRS
Total assets¥3.19Tat 2022-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥892.2bnat 2023-09-30Cons.Liabilities IFRS
Total liabilities¥840.3bnat 2022-12-31Cons.Liabilities IFRS
Net assets / equity¥2.53Tat 2023-09-30Cons.Equity IFRS
Net assets / equity¥2.26Tat 2022-12-31Cons.Equity IFRS
Net assets / equity¥2.33Tat 2022-09-30Cons.Equity IFRS
Net assets / equity¥2.05Tat 2021-12-31dCons.Equity IFRS
Equity (owners)¥2.48Tat 2023-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥2.23Tat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥2.30Tat 2022-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥518.6bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥471.6bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥477.3bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥410.7bnat 2021-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥186.0bn2023-01-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥211.8bn2022-01-01 → 2022-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥171.1bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥74.8bn2023-01-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥81.6bn2022-01-01 → 2022-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥60.4bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥82.4bn2023-01-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥95.5bn2022-01-01 → 2022-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥84.0bn2022-01-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥297.992023-01-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥108.932023-07-01 → 2023-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥246.82022-01-01 → 2022-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥204.662022-01-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥76.042022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥297.992023-01-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥108.932023-07-01 → 2023-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥246.782022-01-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥204.642022-01-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥76.022022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio72.6%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio71.7%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio72.1%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 88
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-01-01 → 2023-09-30¥131.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-07-01 → 2023-09-30¥44.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-01-01 → 2023-09-30¥99.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-07-01 → 2023-09-30¥33.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-01-01 → 2023-09-30¥32.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-07-01 → 2023-09-30¥11.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-09-30¥9.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-07-01 → 2023-09-30¥2.0bn
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-09-30−¥32.9bn
Reconciling Itemsreconcilingrevenue2023-07-01 → 2023-09-30−¥11.7bn
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-09-30−¥32.9bn
Reconciling Itemsreconcilingrevenue intersegment2023-07-01 → 2023-09-30−¥11.7bn
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-09-30−¥37.4bn
Reconciling Itemsreconcilingsegment profit2023-07-01 → 2023-09-30−¥12.1bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue2023-01-01 → 2023-09-30¥28.5bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue2023-07-01 → 2023-09-30¥11.0bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue external2023-01-01 → 2023-09-30¥28.4bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue external2023-07-01 → 2023-09-30¥11.0bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue intersegment2023-01-01 → 2023-09-30¥12m
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue intersegment2023-07-01 → 2023-09-30¥3m
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentsegment profit2023-01-01 → 2023-09-30¥10.6bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentsegment profit2023-07-01 → 2023-09-30¥2.6bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue2023-01-01 → 2023-09-30¥359.1bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue2023-07-01 → 2023-09-30¥132.9bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue external2023-01-01 → 2023-09-30¥359.0bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue external2023-07-01 → 2023-09-30¥132.9bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2023-01-01 → 2023-09-30¥95m
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2023-07-01 → 2023-09-30¥40m
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentsegment profit2023-01-01 → 2023-09-30¥28.3bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentsegment profit2023-07-01 → 2023-09-30¥21.6bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue2023-01-01 → 2023-09-30¥992.4bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue2023-07-01 → 2023-09-30¥354.6bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue external2023-01-01 → 2023-09-30¥992.4bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue external2023-07-01 → 2023-09-30¥354.6bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-09-30¥191.5bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentsegment profit2023-07-01 → 2023-09-30¥57.9bn
—segment totalrevenue2023-01-01 → 2023-09-30¥1.51T
—segment totalrevenue2023-07-01 → 2023-09-30¥543.3bn
—segment totalrevenue external2023-01-01 → 2023-09-30¥1.48T
—segment totalrevenue external2023-07-01 → 2023-09-30¥531.5bn
—segment totalrevenue intersegment2023-01-01 → 2023-09-30¥32.9bn
—segment totalrevenue intersegment2023-07-01 → 2023-09-30¥11.7bn
—segment totalsegment profit2023-01-01 → 2023-09-30¥240.1bn
—segment totalsegment profit2023-07-01 → 2023-09-30¥84.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-01-01 → 2022-09-30¥126.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-07-01 → 2022-09-30¥43.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-01-01 → 2022-09-30¥94.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-07-01 → 2022-09-30¥31.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-01-01 → 2022-09-30¥31.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-07-01 → 2022-09-30¥11.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-09-30¥9.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-07-01 → 2022-09-30¥2.0bn
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-09-30−¥32.0bn
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-09-30−¥11.9bn
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-09-30−¥32.0bn
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2022-09-30−¥11.9bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-09-30−¥34.8bn
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-09-30−¥12.0bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue2022-01-01 → 2022-09-30¥27.0bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue2022-07-01 → 2022-09-30¥10.3bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue external2022-01-01 → 2022-09-30¥27.0bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue external2022-07-01 → 2022-09-30¥10.3bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue intersegment2022-01-01 → 2022-09-30¥18m
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥12m
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentsegment profit2022-01-01 → 2022-09-30¥5.6bn
jpcrp040300-q3r_E21183-000Consumer Productsreportable segmentsegment profit2022-07-01 → 2022-09-30¥3.8bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue2022-01-01 → 2022-09-30¥325.6bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue2022-07-01 → 2022-09-30¥119.9bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue external2022-01-01 → 2022-09-30¥325.6bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue external2022-07-01 → 2022-09-30¥119.9bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2022-01-01 → 2022-09-30¥18m
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥7m
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentsegment profit2022-01-01 → 2022-09-30¥49.8bn
jpcrp040300-q3r_E21183-000Nutraceuticalsreportable segmentsegment profit2022-07-01 → 2022-09-30¥21.6bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue2022-01-01 → 2022-09-30¥819.3bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue2022-07-01 → 2022-09-30¥290.0bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue external2022-01-01 → 2022-09-30¥819.3bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentrevenue external2022-07-01 → 2022-09-30¥290.0bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentsegment profit2022-01-01 → 2022-09-30¥84.5bn
jpcrp040300-q3r_E21183-000Pharmaceuticalsreportable segmentsegment profit2022-07-01 → 2022-09-30¥32.3bn
—segment totalrevenue2022-01-01 → 2022-09-30¥1.30T
—segment totalrevenue2022-07-01 → 2022-09-30¥463.7bn
—segment totalrevenue external2022-01-01 → 2022-09-30¥1.27T
—segment totalrevenue external2022-07-01 → 2022-09-30¥451.8bn
—segment totalrevenue intersegment2022-01-01 → 2022-09-30¥32.0bn
—segment totalrevenue intersegment2022-07-01 → 2022-09-30¥11.9bn
—segment totalsegment profit2022-01-01 → 2022-09-30¥149.7bn
—segment totalsegment profit2022-07-01 → 2022-09-30¥59.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 855
ItemContextValueUnit
Profit loss IFRSCurrentYTDDuration165313000000JPY
Basic earnings loss per share IFRSPrior1YTDDuration204.66
Basic earnings loss per share IFRSCurrentYTDDuration297.99
Diluted earnings loss per share IFRSPrior1YTDDuration204.64
Diluted earnings loss per share IFRSCurrentYTDDuration297.99
Revenue IFRSPrior1QuarterDuration451811000000JPY
Revenue IFRSCurrentQuarterDuration531543000000JPY
Cost of sales IFRSPrior1QuarterDuration152728000000JPY
Cost of sales IFRSCurrentQuarterDuration157491000000JPY
Gross profit IFRSPrior1QuarterDuration299083000000JPY
Gross profit IFRSCurrentQuarterDuration374051000000JPY
Selling general and administrative expenses IFRSPrior1QuarterDuration183933000000JPY
Selling general and administrative expenses IFRSCurrentQuarterDuration204446000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1QuarterDuration975000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentQuarterDuration7365000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1QuarterDuration68557000000JPY
Research and development expenditure recognized as expense during period IFRSCurrentQuarterDuration73533000000JPY
Impairment losses pl IFRSPrior1QuarterDuration6340000000JPY
Impairment losses pl IFRSCurrentQuarterDuration28242000000JPY
Other income IFRSPrior1QuarterDuration6922000000JPY
Other income IFRSCurrentQuarterDuration1428000000JPY
Other expenses IFRSPrior1QuarterDuration447000000JPY
Other expenses IFRSCurrentQuarterDuration4663000000JPY
Operating profit loss IFRSPrior1QuarterDuration47701000000JPY
Operating profit loss IFRSCurrentQuarterDuration71959000000JPY
Finance income IFRSPrior1QuarterDuration7023000000JPY
Finance income IFRSCurrentQuarterDuration4013000000JPY
Finance costs IFRSPrior1QuarterDuration1514000000JPY
Finance costs IFRSCurrentQuarterDuration1598000000JPY
Profit loss before tax IFRSPrior1QuarterDuration53210000000JPY
Profit loss before tax IFRSCurrentQuarterDuration74374000000JPY
Income tax expense IFRSPrior1QuarterDuration10784000000JPY
Income tax expense IFRSCurrentQuarterDuration14119000000JPY
Profit loss IFRSPrior1QuarterDuration42426000000JPY
Profit loss IFRSCurrentQuarterDuration60255000000JPY
Profit loss attributable to owners of parent IFRSPrior1QuarterDuration41265000000JPY
Profit loss attributable to owners of parent IFRSCurrentQuarterDuration59118000000JPY
Profit loss attributable to non controlling interests IFRSPrior1QuarterDuration1160000000JPY
Profit loss attributable to non controlling interests IFRSCurrentQuarterDuration1136000000JPY
Profit loss IFRSPrior1QuarterDuration42426000000JPY
Profit loss IFRSCurrentQuarterDuration60255000000JPY
Basic earnings loss per share IFRSPrior1QuarterDuration76.04
Basic earnings loss per share IFRSCurrentQuarterDuration108.93
Diluted earnings loss per share IFRSPrior1QuarterDuration76.02
Diluted earnings loss per share IFRSCurrentQuarterDuration108.93
Profit loss IFRSPrior1YTDDuration113950000000JPY
Profit loss IFRSCurrentYTDDuration165313000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration127000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration274000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration5727000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-01-01/2023-09-30pass
statement vs summary · revenueconsolidated 2023-07-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass